Ciprofloxacin for treating urethral gonorrhoea in men.
- 1 April 1986
- journal article
- research article
- Published by BMJ in Sexually Transmitted Infections
- Vol. 62 (2) , 86-87
- https://doi.org/10.1136/sti.62.2.86
Abstract
The effectiveness of a single oral dose of ciprofloxacin in eradicating urethral gonorrhoea was assessed in 18 men who received 250 mg and 26 men who were given 100 mg. All patients, including two infected with .beta. lactamase (penicillinase) producing strains of Neisseria gonorrhoeae (PPNG), were cured. The drug had no effect on infection with Chlamydia trachomatis or on the incidence of post gonococcal urethritis. Ciprofloxacin may be useful in patients hypersensitive to penicillins and cephalosporins, and the drug may also be useful in urethral gonorrhoea caused by PPNG strains.This publication has 5 references indexed in Scilit:
- Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteersAntimicrobial Agents and Chemotherapy, 1984
- Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteersEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Treatment of Penicillin-ResistantNeisseria gonorrhoeaewith Oral NorfloxacinNew England Journal of Medicine, 1984
- $bgr;-LACTAMASE-PRODUCING, PENICILLIN-RESISTANT GONOCOCCUSThe Lancet, 1976
- Diagnosis of gonorrhoea by culture on a selective medium containing vancomycin, colistin, nystatin and trimethoprim (VCNT). A comparison with Gram-staining and immunofluorescence.Sexually Transmitted Infections, 1972